A brave new framework for glioma drug development
Kelly Hotchkiss, Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse, Elizabeth S. Duke, Justin D. Lathia, David M. Ashley, Edjah K. Nduom, Georgina V. Long, Kirit Singh, Anthony J. Chalmers, Manmeet S. Ahluwalia, Amy B. Heimberger, Stephen Bagley, Tomoki Todo, Roel G.W. Verhaak, Patrick D. Kelly, Shawn L. Hervey‐Jumper, John de Groot, Anoop P. Patel, Peter E. Fecci, Ian F. Parney, Victoria Wykes, Colin Watts, Terry C. Burns, Nader Sanai, Matthias Preusser, J. C. Tonn, Katharine J. Drummond, Michael Platten, Sunit Das, Kirk Tanner, Michael A. Vogelbaum, Michael Weller, James R. Whittle, Mitchel S. Berger, Mustafa Khasraw
Topics & Concepts
GliomaDrug developmentDrugComputer scienceMedicinePharmacologyCancer researchGlioma Diagnosis and TreatmentATP Synthase and ATPases ResearchCancer, Hypoxia, and Metabolism